<p><strong>Cello World Limited</strong> (NSE:CELLO) 正面臨一個艱難的時期，因其一週前發佈的第三季度業績令人失望，這可能會顯著影響市場對該股票的看法。結果顯示，收入為 ₹55 億，低於分析師預期的 6.3%。法定每股收益 (EPS) 為 ₹2.88，嚴重低於預期，約低了 22%。對於投資者來説，這是一個重要的時刻，因為他們可以在報告中跟蹤公司的表現，查看專家對明年的預測，並觀察業務預期是否有所變化。考慮到這一點，我們收集了最新的法定預測，以瞭解分析師對明年的預期。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/417994730-earnings-and-revenue-growth-1-dark-2/1771380188595?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1642" height="1048" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/417994730-earnings-and-revenue-growth-1-dark-2/1771380188595"/></p>
<p>NSEI:CELLO 收益和收入增長 2026 年 2 月 18 日</p>
<p>考慮到最新的業績，Cello World 七位分析師的共識預測是 2027 年收入為 ₹258 億。這反映出與過去 12 個月相比，收入有顯著的 11% 增長。法定每股收益預計將上漲 23%，達到 ₹17.33。在這份收益報告之前，分析師們預測 2027 年的收入為 ₹279 億，每股收益 (EPS) 為 ₹19.51。近期業績後，分析師們似乎不那麼樂觀，降低了他們的收入預測，並大幅下調了每股收益的預期。</p>
<p>查看我們對 Cello World 的最新分析</p>
<p>共識價格目標下降了 16%，降至 ₹587，疲軟的收益前景顯然導致了估值預期的下滑。共識價格目標只是各個分析師目標的平均值，因此——查看基礎估計的範圍可能會很有幫助。目前，最樂觀的分析師將 Cello World 的每股價值定為 ₹640，而最悲觀的則定為 ₹515。儘管如此，考慮到估計值相對接近，分析師們對他們的估值相當有信心，這表明 Cello World 是一個容易預測的業務，或者分析師們都在使用相似的假設。</p>
<p>獲取這些預測的更多背景的一種方法是查看它們與過去表現的比較，以及同一行業其他公司的表現。我們要強調的是，Cello World 的收入增長預計將放緩，預計到 2027 年底的年化增長率為 8.9%，遠低於過去五年的歷史年均增長率 13%。相比之下，該行業其他有分析師覆蓋的公司預計年收入增長為 14%。考慮到預計的增長放緩，顯然 Cello World 的增長也預計將低於其他行業參與者。</p>
<h2>結論</h2>
<p>最大的擔憂是分析師下調了每股收益的預期，這表明 Cello World 可能面臨業務逆風。不幸的是，他們也下調了收入預期，我們的數據表明其表現低於更廣泛的行業。儘管如此，每股收益對企業的內在價值更為重要。此外，分析師們還下調了他們的價格目標，這表明最新消息導致了對企業內在價值的更大悲觀情緒。</p>
<p>話雖如此，公司的長期收益軌跡遠比明年的表現更為重要。我們有來自多位 Cello World 分析師的預測，直到 2028 年，你可以在我們的平台上免費查看。</p>
<p>另一個需要考慮的因素是管理層和董事最近是否有買入或賣出股票。我們在平台上提供了過去十二個月所有公開市場股票交易的概述。</p>
<h3><strong>新：AI 股票篩選器和警報</strong></h3>
<p>我們的新 AI 股票篩選器每天掃描市場以發現機會。</p>
<p>• 分紅強勁的股票（收益率 3%+）</p>
<p>• 具有內部買入的被低估小盤股</p>
<p>• 高增長的科技和 AI 公司</p>
<p>或者從 50 多個指標中構建自己的篩選器。</p>
<p>立即免費探索</p>

<p>Cello World Limited (NSE:CELLO) 公佈了令人失望的第三季度業績，收入為 55 億印度盧比，比預期低 6.3%，每股收益為 2.88 印度盧比，比預測低 22%。分析師已將 2027 年的收入預測下調至 258 億印度盧比（增長 11%），每股收益下調至 17.33 印度盧比（增長 23%）。共識目標價下降 16% 至 587 印度盧比，反映出盈利前景的降低。Cello World 預期的增長率為 8.9%，低於行業平均水平的 14%。儘管長期盈利預測延續至 2028 年，分析師對潛在的商業逆風和內在價值表示擔憂</p>

<p>It's shaping up to be a tough period for <strong>Cello World Limited</strong> (NSE:CELLO), which a week ago released some disappointing third-quarter results that could have a notable impact on how the market views the stock. Results showed a clear earnings miss, with ₹5.5b revenue coming in 6.3% lower than what the analystsexpected. Statutory earnings per share (EPS) of ₹2.88 missed the mark badly, arriving some 22% below what was expected. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.</p>
<div class="lb-trans"><p><strong>Cello World Limited</strong> (NSE:CELLO) 正面臨一個艱難的時期，因其一週前發佈的第三季度業績令人失望，這可能會顯著影響市場對該股票的看法。結果顯示，收入為 ₹55 億，低於分析師預期的 6.3%。法定每股收益 (EPS) 為 ₹2.88，嚴重低於預期，約低了 22%。對於投資者來説，這是一個重要的時刻，因為他們可以在報告中跟蹤公司的表現，查看專家對明年的預測，並觀察業務預期是否有所變化。考慮到這一點，我們收集了最新的法定預測，以瞭解分析師對明年的預期。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/417994730-earnings-and-revenue-growth-1-dark-2/1771380188595" alt="" original-src="https://images.simplywall.st/asset/chart/417994730-earnings-and-revenue-growth-1-dark-2/1771380188595"/></p>
<p>NSEI:CELLO Earnings and Revenue Growth February 18th 2026</p>
<div class="lb-trans"><p>NSEI:CELLO 收益和收入增長 2026 年 2 月 18 日</p>
</div><p>Taking into account the latest results, the consensus forecast from Cello World's seven analysts is for revenues of ₹25.8b in 2027. This reflects a meaningful 11% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to shoot up 23% to ₹17.33. Before this earnings report, the analysts had been forecasting revenues of ₹27.9b and earnings per share (EPS) of ₹19.51 in 2027. The analysts seem less optimistic after the recent results, reducing their revenue forecasts and making a substantial drop in earnings per share numbers.</p>
<div class="lb-trans"><p>考慮到最新的業績，Cello World 七位分析師的共識預測是 2027 年收入為 ₹258 億。這反映出與過去 12 個月相比，收入有顯著的 11% 增長。法定每股收益預計將上漲 23%，達到 ₹17.33。在這份收益報告之前，分析師們預測 2027 年的收入為 ₹279 億，每股收益 (EPS) 為 ₹19.51。近期業績後，分析師們似乎不那麼樂觀，降低了他們的收入預測，並大幅下調了每股收益的預期。</p>
</div><p>See our latest analysis for Cello World</p>
<div class="lb-trans"><p>查看我們對 Cello World 的最新分析</p>
</div><p>The consensus price target fell 16% to ₹587, with the weaker earnings outlook clearly leading valuation estimates. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Cello World at ₹640 per share, while the most bearish prices it at ₹515. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Cello World is an easy business to forecast or the the analysts are all using similar assumptions.</p>
<div class="lb-trans"><p>共識價格目標下降了 16%，降至 ₹587，疲軟的收益前景顯然導致了估值預期的下滑。共識價格目標只是各個分析師目標的平均值，因此——查看基礎估計的範圍可能會很有幫助。目前，最樂觀的分析師將 Cello World 的每股價值定為 ₹640，而最悲觀的則定為 ₹515。儘管如此，考慮到估計值相對接近，分析師們對他們的估值相當有信心，這表明 Cello World 是一個容易預測的業務，或者分析師們都在使用相似的假設。</p>
</div><p>One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Cello World's revenue growth is expected to slow, with the forecast 8.9% annualised growth rate until the end of 2027 being well below the historical 13% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 14% per year. Factoring in the forecast slowdown in growth, it seems obvious that Cello World is also expected to grow slower than other industry participants.</p>
<div class="lb-trans"><p>獲取這些預測的更多背景的一種方法是查看它們與過去表現的比較，以及同一行業其他公司的表現。我們要強調的是，Cello World 的收入增長預計將放緩，預計到 2027 年底的年化增長率為 8.9%，遠低於過去五年的歷史年均增長率 13%。相比之下，該行業其他有分析師覆蓋的公司預計年收入增長為 14%。考慮到預計的增長放緩，顯然 Cello World 的增長也預計將低於其他行業參與者。</p>
</div><h2>The Bottom Line</h2>
<div class="lb-trans"><h2>結論</h2>
</div><p>The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Cello World. Unfortunately, they also downgraded their revenue estimates, and our data indicates underperformance compared to the wider industry. Even so, earnings per share are more important to the intrinsic value of the business. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.</p>
<div class="lb-trans"><p>最大的擔憂是分析師下調了每股收益的預期，這表明 Cello World 可能面臨業務逆風。不幸的是，他們也下調了收入預期，我們的數據表明其表現低於更廣泛的行業。儘管如此，每股收益對企業的內在價值更為重要。此外，分析師們還下調了他們的價格目標，這表明最新消息導致了對企業內在價值的更大悲觀情緒。</p>
</div><p>With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Cello World analysts - going out to 2028, and you can see them free on our platform here.</p>
<div class="lb-trans"><p>話雖如此，公司的長期收益軌跡遠比明年的表現更為重要。我們有來自多位 Cello World 分析師的預測，直到 2028 年，你可以在我們的平台上免費查看。</p>
</div><p>Another thing to consider is whether management and directors have been buying or selling stock recently. We provide an overview of all open market stock trades for the last twelve months on our platform, here.</p>
<div class="lb-trans"><p>另一個需要考慮的因素是管理層和董事最近是否有買入或賣出股票。我們在平台上提供了過去十二個月所有公開市場股票交易的概述。</p>
</div><h3><strong>New:</strong> AI Stock Screener &amp; Alerts</h3>
<div class="lb-trans"><h3><strong>新：AI 股票篩選器和警報</strong></h3>
</div><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p>
<div class="lb-trans"><p>我們的新 AI 股票篩選器每天掃描市場以發現機會。</p>
</div><p>• Dividend Powerhouses (3%+ Yield)</p>
<div class="lb-trans"><p>• 分紅強勁的股票（收益率 3%+）</p>
</div><p>• Undervalued Small Caps with Insider Buying</p>
<div class="lb-trans"><p>• 具有內部買入的被低估小盤股</p>
</div><p>• High growth Tech and AI Companies</p>
<div class="lb-trans"><p>• 高增長的科技和 AI 公司</p>
</div><p>Or build your own from over 50 metrics.</p>
<div class="lb-trans"><p>或者從 50 多個指標中構建自己的篩選器。</p>
</div><p>Explore Now for Free</p>
<div class="lb-trans"><p>立即免費探索</p>
</div>

Cello World Limited 剛剛未能達到盈利預期，但分析師們已經更新了他們的模型